These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22613376)

  • 21. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children.
    Araki S; Dobashi K; Kubo K; Kawagoe R; Yamamoto Y; Kawada Y; Asayama K; Shirahata A
    Obesity (Silver Spring); 2008 Feb; 16(2):384-8. PubMed ID: 18239648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
    Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation.
    Akın L; Kurtoglu S; Yikilmaz A; Kendirci M; Elmalı F; Mazicioglu M
    Acta Paediatr; 2013 Mar; 102(3):e107-13. PubMed ID: 23190373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?
    Rodríguez G; Gallego S; Breidenassel C; Moreno LA; Gottrand F
    Nutr Hosp; 2010; 25(5):712-7. PubMed ID: 21336425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
    Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
    Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome.
    Kolsgaard ML; Wangensteen T; Brunborg C; Joner G; Holven KB; Halvorsen B; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2009; 69(8):858-64. PubMed ID: 19929281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
    Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
    Pirgon O; Bilgin H; Tolu I; Odabas D
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
    Papandreou D; Karabouta Z; Pantoleon A; Rousso I
    Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visfatin and TGF-Β1 in primary biliary cirrhosis and two other common liver diseases.
    Waluga M; Kukla M; Żorniak M; Kochel-Jankowska A; Kajor M; Krzemiński T; Kotulski R
    Folia Med Cracov; 2015; 55(4):59-70. PubMed ID: 26867120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
    Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
    Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
    Louthan MV; Barve S; McClain CJ; Joshi-Barve S
    J Pediatr; 2005 Dec; 147(6):835-8. PubMed ID: 16356442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
    Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
    Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
    Radetti G; Kleon W; Stuefer J; Pittschieler K
    Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.